Logos Global Management »

Ibio shares owned by Logos Global Management

Quarter-by-quarter ownership of Ibio (IBIO) shares owned by Logos Global Management from 13F filings

Historical chart of Logos Global Management investment in Ibio

Tip: Access up to 7 years of quarterly data

All positions including Ibio held by Logos Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ibio by Logos Global Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.9M 2.0M 1.93

More positions owned by Logos Global Management

Revolution Medicines Call Option (RVMD)
Ideaya Biosciences (IDYA)
Praxis Precision Medicines I Com New (PRAX)
Olema Pharmaceuticals (OLMA)
Cidara Therapeutics Com New (CDTX)
Abivax Sa Sponsored Ads (ABVX)
Erasca (ERAS)
Ocular Therapeutix (OCUL)
Structure Therapeutics Sponsored Ads (GPCR)
Disc Medicine (IRON)
Maze Therapeatics (MAZE)
Tango Therapeutics (TNGX)
Avidity Biosciences Ord (RNA)
Biogen Idec (BIIB)
Immunovant (IMVT)

View all positions for Logos Global Management

Top funds holding Ibio

Logos Global Management
Lynx1 Capital Management
Vanguard Group
Ikarian Capital
Ameriprise Financial
ADAR1 Capital Management
Opaleye Management
Renaissance Technologies
Hudson Bay Capital Management
Noesis Capital Management Corp.
Geode Capital Management
Walleye Trading Advisors
Boothbay Fund Management
Leucadia National Corporation
Citadel Advisors

View all funds holding Ibio